Literature DB >> 24551675

An 8 years retrospective study of breast cancer incidence in ilam province, Western iran.

Yasemi M1, Hafezi Ahmadi M R2, Khajavikhan J3, Peyman H4, Asadollahi K H5, Yasemi M R6, Hemati K7.   

Abstract

INTRODUCTION: Breast cancer is the most common cancer (27% of all cancers) and common cause of death (16%) which occurs due to cancers among women, either in developed or developing countries. The current study aimed to assess incidence of breast cancer in west of Iran (Ilam province).
METHODS: During a cross-sectional study, all documented records of patients who were referred to the health centre of Ilam province in a period of 8 years (2002-2009) were investigated and 82 files which were related to breast cancer were identified. Patients' data were entered into SPSS, version 16 and using X2, t-test and descriptive statistics, they were analyzed.
RESULTS: Totally, 82 confirmed breast cancer cases were diagnosed between 2002-2009 and this figure accounted for 21.4% of all cancers in Ilam province. The mean age with standard deviation (SD) of patients was 47.4 ± 14.5 years and the disease was most frequent in the age group of 30-40 years (38.3%). The highest incidence rate was seen in 2006- 2007 and the lowest rate was seen in 2002-2003. The most prevalent morphologic pattern of breast caner (86.2%) was invasive ductal carcinoma (IDC). There was a 23% incidence rate for breast cancer, with a significant increase in its incidence rate during 2002-2009.
CONCLUSION: Due to diagnosis of the disease in its advanced stages, and also involvement of low age groups and young population in the country, screening programs such as self examination, examination by doctors and mammography should be started in the lower age groups, in ages which are lower than 30 years.

Entities:  

Keywords:  Breast cancer; Breast self examination-incidence-ilam

Year:  2013        PMID: 24551675      PMCID: PMC3919362          DOI: 10.7860/JCDR/2013/7633.3709

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  11 in total

1.  Cancer Incidence in Five Continents. Comparability and quality of data.

Authors:  D M Parkin; C S Muir
Journal:  IARC Sci Publ       Date:  1992

2.  Cancer of the breast: the past decade (second of two parts).

Authors:  I C Henderson; G P Canellos
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

3.  Global cancer statistics, 2002.

Authors:  D Max Parkin; Freddie Bray; J Ferlay; Paola Pisani
Journal:  CA Cancer J Clin       Date:  2005 Mar-Apr       Impact factor: 508.702

Review 4.  Five common cancers in Iran.

Authors:  Shadi Kolahdoozan; Alireza Sadjadi; Amir Reza Radmard; Hooman Khademi
Journal:  Arch Iran Med       Date:  2010-03       Impact factor: 1.354

5.  Cancer incidence and mortality in Iran.

Authors:  S M Mousavi; M M Gouya; R Ramazani; M Davanlou; N Hajsadeghi; Z Seddighi
Journal:  Ann Oncol       Date:  2008-12-10       Impact factor: 32.976

6.  Management of primary, operable breast cancer in Victoria.

Authors:  D J Hill; G G Giles; I S Russell; J P Collins; K J Mapperson
Journal:  Med J Aust       Date:  1990-01-15       Impact factor: 7.738

7.  A mammographic screening pilot project in Victoria 1988-1990. The Essendon Breast X-ray Program Collaborative Group.

Authors: 
Journal:  Med J Aust       Date:  1992-11-16       Impact factor: 7.738

8.  Recent incidence trends for breast cancer in women and the relevance of early detection: an update.

Authors:  B A Miller; E J Feuer; B F Hankey
Journal:  CA Cancer J Clin       Date:  1993 Jan-Feb       Impact factor: 508.702

9.  Breast cancer in Iran: need for greater women awareness of warning signs and effective screening methods.

Authors:  Ali Montazeri; Mariam Vahdaninia; Iraj Harirchi; Amir Mahmood Harirchi; Akram Sajadian; Fatemeh Khaleghi; Mandana Ebrahimi; Shahpar Haghighat; Soghra Jarvandi
Journal:  Asia Pac Fam Med       Date:  2008-12-20

10.  Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000.

Authors:  Kenji Shibuya; Colin D Mathers; Cynthia Boschi-Pinto; Alan D Lopez; Christopher J L Murray
Journal:  BMC Cancer       Date:  2002-12-26       Impact factor: 4.430

View more
  4 in total

1.  Britannin, a sesquiterpene lactone, inhibits proliferation and induces apoptosis through the mitochondrial signaling pathway in human breast cancer cells.

Authors:  Maryam Hamzeloo-Moghadam; Mahmoud Aghaei; Faranak Fallahian; Seyyed Mehdi Jafari; Masoumeh Dolati; Mohammad Hossein Abdolmohammadi; Sima Hajiahmadi; Somayeh Esmaeili
Journal:  Tumour Biol       Date:  2014-10-24

2.  Predictors of Quality of Life in Patients with Breast Cancer.

Authors:  Fahimeh Sehhatie Shafaie; Mojgan Mirghafourvand; Jalileh Amirzehni
Journal:  Indian J Palliat Care       Date:  2019 Jan-Mar

3.  Tissue polypeptide antigen & interleukin-6: Are their serum levels a predictor for response to chemotherapy in breast cancer?

Authors:  Wahda Basheer Al-Youzbaki; Niaam Basheer Al-Youzbaki; Muwaffaq M Telfah
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

4.  Mitochondrial and caspase pathways are involved in the induction of apoptosis by nardosinen in MCF-7 breast cancer cell line.

Authors:  Amirhosein Shahali; Mustafa Ghanadian; Seyyed Mehdi Jafari; Mahmoud Aghaei
Journal:  Res Pharm Sci       Date:  2018-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.